share_log

TCR2 Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL PARTNERS, LP(7.3%),TANG CAPITAL MANAGEMENT, LLC(7.3%), etc.

TCR2 Therapeutics | SC 13G:超过5%持股股东披露文件-TANG CAPITAL PARTNERS, LP(7.3%),TANG CAPITAL MANAGEMENT, LLC(7.3%)等

2022/03/04 16:00
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息